Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten L Simoons

Showing results (71-80 of 185) with videos related to

Pageof 19
Sort By:
Journal of Electrocardiology|April 25, 2008
Simultaneous comparison of 3 derived 12-lead electrocardiograms with standard electrocardiogram at rest and during percutaneous coronary occlusionStefan P Nelwan, Jan A Kors, Suzanne W Crater, et al.
European Heart Journal|July 6, 2006
Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromesTimo Lenderink, Eric Boersma, Anselm K Gitt, et al.
European Heart Journal|February 25, 2006
Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of riskJaap W Deckers, Dick M Goedhart, Eric Boersma, et al.
The American Journal of Cardiology|April 28, 2004
Long-term outcome and quality of life in adult patients after the Fontan operationAnnemien E van den Bosch, Jolien W Roos-Hesselink, Ron Van Domburg, et al.
American Heart Journal|June 25, 2004
Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUITWei-Ching Chang, Eric Boersma, Christopher B Granger, et al.
European Heart Journal|April 7, 2009
The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trialsJasper J Brugts, Toshiharu Ninomiya, Eric Boersma, et al.
Journal of the American College of Cardiology|March 26, 2003
Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudyStefan K James, Paul Armstrong, Elliott Barnathan, et al.
The American Journal of Cardiology|July 16, 2003
Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromesDeepak L Bhatt, Derek P Chew, A Michael Lincoff, et al.
Current Opinion in Cardiology|June 4, 2008
Pharmacogenetics of ACE inhibition in stable coronary artery disease: steps towards tailored drug therapyJasper J Brugts, A H Jan Danser, Moniek P M de Maat, et al.
The American Journal of Cardiology|August 14, 2012
Frequency of asymptomatic disease among family members with noncompaction cardiomyopathyKadir Caliskan, Michelle Michels, Marcel L Geleijnse, et al.
Pageof 19

Showing results (71-80 of 185) with videos related to

Sort By:
Pageof 19
Journal of Electrocardiology|April 25, 2008
Simultaneous comparison of 3 derived 12-lead electrocardiograms with standard electrocardiogram at rest and during percutaneous coronary occlusionStefan P Nelwan, Jan A Kors, Suzanne W Crater, et al.
European Heart Journal|July 6, 2006
Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromesTimo Lenderink, Eric Boersma, Anselm K Gitt, et al.
European Heart Journal|February 25, 2006
Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of riskJaap W Deckers, Dick M Goedhart, Eric Boersma, et al.
The American Journal of Cardiology|April 28, 2004
Long-term outcome and quality of life in adult patients after the Fontan operationAnnemien E van den Bosch, Jolien W Roos-Hesselink, Ron Van Domburg, et al.
American Heart Journal|June 25, 2004
Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUITWei-Ching Chang, Eric Boersma, Christopher B Granger, et al.
European Heart Journal|April 7, 2009
The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trialsJasper J Brugts, Toshiharu Ninomiya, Eric Boersma, et al.
Journal of the American College of Cardiology|March 26, 2003
Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudyStefan K James, Paul Armstrong, Elliott Barnathan, et al.
The American Journal of Cardiology|July 16, 2003
Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromesDeepak L Bhatt, Derek P Chew, A Michael Lincoff, et al.
Current Opinion in Cardiology|June 4, 2008
Pharmacogenetics of ACE inhibition in stable coronary artery disease: steps towards tailored drug therapyJasper J Brugts, A H Jan Danser, Moniek P M de Maat, et al.
The American Journal of Cardiology|August 14, 2012
Frequency of asymptomatic disease among family members with noncompaction cardiomyopathyKadir Caliskan, Michelle Michels, Marcel L Geleijnse, et al.
Pageof 19